Correction: A Comprehensive Review of Stereotactic Radiotherapy for Brain Metastases

Overview

This correction addresses omissions in the captions of figures related to stereotactic radiotherapy for brain metastases.

Background

Stereotactic radiotherapy (SRT) is a treatment modality for brain metastases. This correction addresses omissions in figure captions.

Data Highlights

No numerical or trial data provided in the source material.

Key Findings

• The correction pertains to the omission of attribution to BioGDP.com in figure captions.
• Figure 2 summarizes advances and optimization strategies in stereotactic radiotherapy.
• Figure 3 illustrates mechanisms of radiotherapy combined with targeted therapy and immunotherapy.
• Both figures are integral to understanding the treatment of brain metastases.
• The original article has been updated to reflect these corrections.

Clinical Implications

Accurate figure captions are vital for clinicians and researchers to interpret data correctly. This correction reinforces the importance of thorough peer review in scientific publications.

Conclusion

The correction ensures that the figures accurately represent the contributions of BioGDP.com.

Related Resources & Content

1. Chen H, Li S, Yang Q, Zhou F, Front. Oncol, 2026 -- A Comprehensive Review of Stereotactic Radiotherapy for Brain Metastases
2. The ASCO Post — Which Factors Influence Radiotherapy for Brain Metastases?
3. Journal of Neuro-Oncology — The role of stereotactic radiosurgery in the management of patients with newly diagnosed brain metastases: a systematic review and evidence-based clinical practice guideline
4. Upfront stereotactic radiosurgery for large posterior fossa metastases: a multicenter evaluation of clinical outcomes
5. The ASCO Post — Stereotactic vs Whole-Brain Radiation for Patients With Brain Metastases
6. Treatment for Brain Metastases: ASCO-SNO-ASTRO Guideline - PMC
7. Treatment for Brain Metastases With Stereotactic Radiation vs Hippocampal-Avoidance Whole Brain Radiation: A Randomized Clinical Trial - PubMed
8. Frontiers | Efficacy and safety of immune checkpoint inhibitors for brain metastases of non-small cell lung cancer: a systematic review and network meta-analysis